Oncology service initiatives and research in regional Australia.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 25689382)

Published in Aust J Rural Health on February 01, 2015

Authors

Caitlin Murphy1, Sabe Sabesan, Christopher Steer, Patsy Yates, Anne Booms, Victoria Jones, Alison Simpson, Kerrie Clarke, Richard Eek, David Ashley, David Goldstein, Chris Packer, Fiona Tuthill, Adam Boyce, Craig Underhill

Author Affiliations

1: Austin Health, Melbourne, Queensland, Australia.

Articles by these authors

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2007) 25.52

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol (2003) 15.10

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol (2006) 6.92

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol (2012) 4.91

Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology (2008) 4.50

Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science (2003) 3.59

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem (2005) 3.15

HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. J Clin Oncol (2005) 2.68

Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res (2008) 2.66

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol (2014) 2.64

A systematic review of the effect of waiting for treatment for chronic pain. Pain (2007) 2.52

Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol (2012) 2.40

Biological variation of glycohemoglobin. Clin Chem (2002) 2.38

Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat Med (2013) 2.19

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS (2010) 1.99

Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust (2007) 1.99

Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure. Oral Oncol (2012) 1.98

Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol (2004) 1.88

Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol (2010) 1.87

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol (2008) 1.87

Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer Res (2008) 1.77

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol (2007) 1.74

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol (2010) 1.73

Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol (2009) 1.70

A clinical pathway for bronchiolitis is effective in reducing readmission rates. J Pediatr (2005) 1.68

Half of patients with obstructive sleep apnea have a higher NREM AHI than REM AHI. Sleep Med (2006) 1.66

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy. Blood (2008) 1.64

Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis (2002) 1.64

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology (2011) 1.59

A randomised controlled trial of computer-assisted interviewing in sexual health clinics. Sex Transm Infect (2010) 1.58

Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases. Head Neck (2008) 1.56

Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study. Clin Cancer Res (2011) 1.56

Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile? Eur J Cancer (2010) 1.55

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. J Natl Cancer Inst (2013) 1.54

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain (2009) 1.50

International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature. J Clin Oncol (2007) 1.50

Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases. BMC Cancer (2006) 1.49

Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women's Wellness Program. Menopause (2015) 1.46

Detection of water in the LCROSS ejecta plume. Science (2010) 1.44

Multiple origins of Ashkenazi Levites: Y chromosome evidence for both Near Eastern and European ancestries. Am J Hum Genet (2003) 1.44

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer (2007) 1.44

Enhancing the supportive care of parents with advanced cancer: development of a self-directed educational manual. Eur J Cancer (2008) 1.42

Factors influencing oncology nurses' approaches to accommodating cultural needs in palliative care. J Clin Nurs (2009) 1.40

Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure". Oral Oncol (2013) 1.40

Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group. Leuk Lymphoma (2011) 1.39

Oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve (2005) 1.37

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol (2009) 1.37

Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin (2014) 1.36

STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int J Oncol (2012) 1.36

Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One (2011) 1.35

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer (2006) 1.35

Remoteness of residence and survival from cancer in New South Wales. Med J Aust (2004) 1.33

Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy. J Clin Oncol (2011) 1.29

Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from domestic cigarettes. Environ Sci Technol (2005) 1.28

Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry (2007) 1.26

Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report. BMC Cancer (2004) 1.26

Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure. Clin Cancer Res (2012) 1.25

Genomic microsatellites as evolutionary chronometers: a test in wild cats. Genome Res (2002) 1.25

Framing effects in younger and older adults. J Gerontol B Psychol Sci Soc Sci (2005) 1.22

Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. Oncologist (2011) 1.22

Long-term regional control and survival in patients with "low-risk," early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Cancer (2012) 1.21

The Australian Palliative Care Outcomes Collaboration (PCOC)--measuring the quality and outcomes of palliative care on a routine basis. Aust Health Rev (2010) 1.20

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res (2006) 1.19

Time of day, Intellectual Performance, and Behavioral Problems in Morning Versus Evening type Adolescents: Is there a Synchrony Effect? Pers Individ Dif (2007) 1.15

Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library. Antimicrob Agents Chemother (2003) 1.14

Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck (2008) 1.14

A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol (2008) 1.13

Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med (2006) 1.10

Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review. Support Care Cancer (2011) 1.10

Are Australian oncology health professionals burning out? A view from the trenches. Eur J Cancer (2008) 1.09

Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol (2011) 1.09

Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol (2007) 1.08

The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg Med Chem (2011) 1.07

Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol (2002) 1.07

Quality of life in patients with maxillectomy prostheses. Head Neck (2009) 1.04

A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics (2012) 1.04

Inequity in rural cancer survival in Australia is not an insurmountable problem. Med J Aust (2006) 1.04

Age differences in choice satisfaction: a positivity effect in decision making. Psychol Aging (2008) 1.04

A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Support Care Cancer (2010) 1.03

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary. Int J Gynecol Cancer (2014) 1.03

A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence. BMC Cancer (2011) 1.02

Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev (2008) 1.02

Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. Haematologica (2005) 1.02

Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor. J Clin Oncol (2004) 1.02

White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol (2004) 1.02

From inside the bubble: migrants' perceptions of communication with the cancer team. Support Care Cancer (2010) 1.01

Development of a resource for parents with advanced cancer: what do parents want? Palliat Support Care (2007) 1.01

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer. Am J Clin Oncol (2009) 1.01

Cost savings from a telemedicine model of care in northern Queensland, Australia. Med J Aust (2013) 1.00

Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors. PLoS Comput Biol (2009) 1.00

Oxaliplatin and axonal Na+ channel function in vivo. Clin Cancer Res (2006) 1.00

New drugs for children and adolescents with cancer: the need for novel development pathways. Lancet Oncol (2013) 1.00